Importance To our knowledge, there is no consensus regarding differences in treatment and
mortality between non-Hispanic African American and non-Hispanic White women with triple …

Introduction A review was conducted to summarize the current evidence and gaps in the
literature on geographic access to mammography and its relationship to breast cancer …

Abstract Purpose of Review Differences in socioeconomic status (SES) and social
determinants of health (SDH) account for many of the disparities seen among patients …

Adjuvant endocrine therapy for breast cancer reduces recurrence and improves survival
rates. Many patients never start treatment or discontinue prematurely. A better …

Purpose Neoadjuvant chemotherapy (NAC) for triple-negative breast cancer (TNBC) allows
for assessment of tumor pathological response and has survival implications. In 2017, the …

BACKGROUND Young age at diagnosis has a negative prognostic impact on outcome in
patients with breast cancer (BC). In the current study, the authors sought to determine …

Chemotherapy improves breast cancer survival but is underused more often in black than in
white women. We examined associations between patient–physician relationships and …

Background Breast cancer survival disparities by race are likely multifactorial. In a small pilot
cohort, we demonstrated a statistical interaction between age and race. The purpose of this …

Background In racially diverse communities, treatment of chronic diseases can vary across
racial and ethnic groups. Objectives To examine healthcare disparities in hemophilia care in …

Purpose Patients with early breast cancer and coexistent comorbidities generally
experience worse prognosis which may be in part related to inferior treatment. Randomised …